Top in ID: Bone and joint infections; human rabies breakthrough infections
Among people who inject drugs, partial-oral antibiotic treatment for bone and joint infections was effective when paired with medical respite and specialized follow-up care, researchers reported.
Wei Teng-Yang, MD, MPH, an addiction medicine fellow at Oregon Health & Science University, told Healio that “once we can stabilize patients' substance use disorders (primarily opioid use disorder), oral antibiotics should be a practical option.” It was the top story in infectious disease last week.
Another top story was about the role of poor treatment administration in breakthrough human rabies infections.
Read these and more top stories in infectious disease below:
Hospital improves cure rate of bone and joint infections with oral antibiotics
A hospital improved the cure rate of bone and joint infections from 50% to 80% with partial-oral antibiotic treatment and carefully coordinated post-discharge care, according to a study published in Open Forum Infectious Diseases. Read more.
Human rabies breakthrough infections rate attributable to treatment administration errors
Human rabies breakthrough infections are rare. However, researchers found that when they occur, they can be attributed to deviations from core practices or errors in administration of vaccination or rabies immunoglobulin. Read more.
Uganda declares end of Ebola outbreak that killed 55
Health officials declared an end to an Ebola outbreak in Uganda that killed 55 people and infected at least 142 in less than 4 months. Read more.
Integrating ID, substance use care reduces risk for readmission, death
Patients with injection drug use-associated infections were less likely to be readmitted to the hospital or die when they were treated by a clinical team that integrated infectious disease and substance use disorder care, researchers found. Read more.
Cannabis use linked to lower ART adherence in older adults with HIV
Cannabis use was linked to a lower ART adherence among older patients with HIV compared with patients who never use the drug, according to a study published in Open Forum Infectious Diseases. Read more.